Current practice in the management of superficial bladder cancer in the Netherlands and Belgian flanders: A survey

European Urology

Volumn 49, Issue 3, 2006, Pages 478-484

  Witjes, J A ^a   Melissen, D O T M ^a   Kiemeney, L A L M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bladder cancer; Diagnosis; Follow up; Survey; Therapy

Indexed keywords

BCG VACCINE; EPIRUBICIN; MITOMYCIN C;

BELGIUM; BLADDER CANCER; CANCER PATIENT; CYSTOSCOPY; DISEASE MANAGEMENT; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MEDICAL PRACTICE; NETHERLANDS; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; STATISTICAL ANALYSIS; UROLOGY;

EID: 32944465698     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.11.010     Document Type: Article

References (17)

1. W. Oosterlinck, B. Lobel, G. Jakse, P.U. Malmstrom, M. Stockle, and C. Sternberg Guidelines on bladder cancer Eur Urol 41 2002 105 112
2. J.A. Smith Jr., R.F. Labasky, A.T. Cockett, J.A. Fracchia, J.E. Montie, and R.G. Rowland Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association J Urol 162 1999 1697 1701
3. H.D. Wazait, S.Z. Al Bhueissi, H.R. Patel, M.S. Nathan, and R.A. Miller Long-term surveillance of bladder tumours: current practice in the UK and Ireland Eur Urol 43 2003 485 488
4. F.N. Joudi, B.J. Smith, M.A. O'Donnell, and B.R. Konety Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis Urology 62 2003 1083 1088
5. D. Schrag, L.J. Hsieh, F. Rabbani, P.B. Bach, H. Herr, and B. Begg Adherence to surveillance among patients with superficial bladder cancer J Natl Cancer Inst 95 2003 588 597
6. C. Snyder, L. Harlan, K. Knopf, A. Potosky, and R. Kaplan Patterns of care for the treatment of bladder cancer J Urol 169 2003 1697 1701
7. D. Chung, K. Hersey, and N. Flehner Differences between urologists in United States and Canada in approach to bladder cancer Urology 65 2005 919 925
8. B.W. van Rhijn, H.G. van der Poel, and T.H. van der Kwast Urine markers for bladder cancer surveillance: a systematic review Eur Urol 47 2005 736 748
9. R.J. Sylvester, W. Oosterlinck, and A.P. van der Meijden A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 171 2004 2186 2190
10. C. Obek, S.W. Shelfo, H.J. Korman, and M.S. Soloway Intravesical therapy for transitional cell carcinoma of the bladder: the community practice Urology 53 1999 82 87
11. M.A. Ghoneim, M.M. el Mekresh, M.A. el Baz, I.A. el Attar, and A. Ashamallah Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases J Urol 158 1997 393 399
12. D. Esrig, J.A. Freeman, J.P. Stein, and D.G. Skinner Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder Semin Urol Oncol 15 1997 154 160
13. H.W. Herr, and P.C. Sogani Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166 2001 1296 1299
14. F.M. Brown Urine cytology. Is it still the gold standard for screening? Urol Clin North Am 27 2000 25 37
15. Y. Lotan, and C.G. Roehrborn Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses Urology 61 2003 109 118
16. S. Holmang, H. Hedelin, C. Anderstrom, E. Holmberg, and S.L. Johansson Long-term followup of a bladder carcinoma cohort: routine followup urography is not necessary J Urol 160 1998 45 48
17. E. Solsona, I. Iborra, J.V. Ricos, R. Dumont, J.L. Casanova, and C. Calabuig Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management Urology 49 1997 347 352